These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 36010965)

  • 1. Recent Advances and Challenges in Cancer Immunotherapy.
    Peterson C; Denlinger N; Yang Y
    Cancers (Basel); 2022 Aug; 14(16):. PubMed ID: 36010965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunotherapeutic Agents for Intratumoral Immunotherapy.
    Shyr CR; Liu LC; Chien HS; Huang CP
    Vaccines (Basel); 2023 Nov; 11(11):. PubMed ID: 38006049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer immunotherapy: harnessing the immune system to battle cancer.
    Yang Y
    J Clin Invest; 2015 Sep; 125(9):3335-7. PubMed ID: 26325031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Translational landscape of glioblastoma immunotherapy for physicians: guiding clinical practice with basic scientific evidence.
    Kreatsoulas D; Bolyard C; Wu BX; Cam H; Giglio P; Li Z
    J Hematol Oncol; 2022 Jun; 15(1):80. PubMed ID: 35690784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-viral nano-immunotherapeutics targeting tumor microenvironmental immune cells.
    Yong SB; Chung JY; Song Y; Kim J; Ra S; Kim YH
    Biomaterials; 2019 Oct; 219():119401. PubMed ID: 31398571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Ex Vivo 3D Tumor Microenvironment-Mimicry Culture to Study TAM Modulation of Cancer Immunotherapy.
    Li YR; Yu Y; Kramer A; Hon R; Wilson M; Brown J; Yang L
    Cells; 2022 May; 11(9):. PubMed ID: 35563889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in nano-immunotherapy for hematological malignancies.
    Xu J; Liu W; Fan F; Zhang B; Sun C; Hu Y
    Exp Hematol Oncol; 2024 May; 13(1):57. PubMed ID: 38796455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leveraging NKG2D Ligands in Immuno-Oncology.
    Fuertes MB; Domaica CI; Zwirner NW
    Front Immunol; 2021; 12():713158. PubMed ID: 34394116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineering chimeric antigen receptor T cells for solid tumour therapy.
    Liu L; Qu Y; Cheng L; Yoon CW; He P; Monther A; Guo T; Chittle S; Wang Y
    Clin Transl Med; 2022 Dec; 12(12):e1141. PubMed ID: 36495108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shaping Polarization Of Tumor-Associated Macrophages In Cancer Immunotherapy.
    Gao J; Liang Y; Wang L
    Front Immunol; 2022; 13():888713. PubMed ID: 35844605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multifunctional nanocomposites modulating the tumor microenvironment for enhanced cancer immunotherapy.
    Sharma P; Otto M
    Bioact Mater; 2024 Jan; 31():440-462. PubMed ID: 37701452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Immunotherapy in Targeting the Bone Marrow Microenvironment in Multiple Myeloma: An Evolving Therapeutic Strategy.
    Chung C
    Pharmacotherapy; 2017 Jan; 37(1):129-143. PubMed ID: 27870103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CAR-T Therapy for Pediatric High-Grade Gliomas: Peculiarities, Current Investigations and Future Strategies.
    Antonucci L; Canciani G; Mastronuzzi A; Carai A; Del Baldo G; Del Bufalo F
    Front Immunol; 2022; 13():867154. PubMed ID: 35603195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor Microenvironment Immunosuppression: A Roadblock to CAR T-Cell Advancement in Solid Tumors.
    Johnson A; Townsend M; O'Neill K
    Cells; 2022 Nov; 11(22):. PubMed ID: 36429054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Immunotherapy and Immunosuppressive Signaling in Therapy-Resistant Prostate Cancer.
    Xu P; Wasielewski LJ; Yang JC; Cai D; Evans CP; Murphy WJ; Liu C
    Biomedicines; 2022 Jul; 10(8):. PubMed ID: 35892678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of Immunological Synapse in Predicting the Efficacy of Chimeric Antigen Receptor (CAR) Immunotherapy.
    Liu D; Badeti S; Dotti G; Jiang JG; Wang H; Dermody J; Soteropoulos P; Streck D; Birge RB; Liu C
    Cell Commun Signal; 2020 Aug; 18(1):134. PubMed ID: 32843053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting tumor-associated macrophages as an antitumor strategy.
    Cheng N; Bai X; Shu Y; Ahmad O; Shen P
    Biochem Pharmacol; 2021 Jan; 183():114354. PubMed ID: 33279498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Single-Cell Level Perspective of the Tumor Microenvironment and Its Remodeling by CAR-T Cells.
    Gao S; Sugimura R
    Cancer Treat Res; 2022; 183():275-285. PubMed ID: 35551664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanoscale Metal-Organic Frameworks for Cancer Immunotherapy.
    Ni K; Luo T; Nash GT; Lin W
    Acc Chem Res; 2020 Sep; 53(9):1739-1748. PubMed ID: 32808760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotherapy for Breast Cancer: Current and Future Strategies.
    Williams AD; Payne KK; Posey AD; Hill C; Conejo-Garcia J; June CH; Tchou J
    Curr Surg Rep; 2017 Dec; 5():. PubMed ID: 29657904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.